Clinical Trial

External Validation os the ACME Scoring System

Study acronym: ACME_2
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Acute calculous cholecystitis (ACC) is the second most frequent surgical condition in emergency departments. The recommended treatment is surgical treatment (ST) and the accepted mortality is \<1%, but in severe and/or fragile patients is higher. Despite the Tokyo Guidelines, there no consensus on who is the unfit patient for ST. A recent study has identified 4 risk factors that predicts the mortality in a 92% of patients (ACME) and could help to develop new guidelines in ACC. The aim of this study is to perfom an external validation of the new simplified scoring system for mortality in ACC.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-01-18.
Trial Details
NCT Number NCT06228027
Lead Sponsor Hospital del Mar
Conditions Acute Cholecystitis
Enrollment 10,000 participants
Start Date 2025-01-01
Primary Completion 2027-01-01 (estimated)
Study Completion 2027-04-15 (estimated)
Updated on ClinicalTrials.gov 2024-03-12